| Literature DB >> 32197038 |
Henrik Heitmann1, Bernhard Haller2, Laura Tiemann1, Mark Mühlau1, Achim Berthele1, Thomas R Tölle1, Anke Salmen3,4, Björn Ambrosius3, Antonios Bayas5, Susanna Asseyer6, Hans-Peter Hartung7, Christoph Heesen8, Martin Stangel9, Brigitte Wildemann10, Sarah Haars11, Sergiu Groppa12, Felix Luessi12, Tania Kümpfel13, Sandra Nischwitz14, Sven G Meuth15, Luisa Klotz15, Ralf A Linker16, Uwe K Zettl17, Ulf Ziemann18, Hayrettin Tumani19,20, Björn Tackenberg21, Frauke Zipp12, Heinz Wiendl15, Ralf Gold3, Bernhard Hemmer1,22, Markus Ploner1.
Abstract
Pain is frequent in multiple sclerosis (MS) and includes different types, with neuropathic pain (NP) being most closely related to MS pathology. However, prevalence estimates vary largely, and causal relationships between pain and biopsychosocial factors in MS are largely unknown. Longitudinal studies might help to clarify the prevalence and determinants of pain in MS. To this end, we analyzed data from 410 patients with newly diagnosed clinically isolated syndrome or relapsing-remitting MS participating in the prospective multicenter German National MS Cohort Study (NationMS) at baseline and after 4 years. Pain was assessed by self-report using the PainDETECT Questionnaire. Neuropsychiatric assessment included tests for fatigue, depression, and cognition. In addition, sociodemographic and clinical data were obtained. Prevalence of pain of any type was 40% and 36% at baseline and after 4 years, respectively, whereas prevalence of NP was 2% and 5%. Pain of any type and NP were both strongly linked to fatigue, depression, and disability. This link was even stronger after 4 years than at baseline. Moreover, changes in pain, depression, and fatigue were highly correlated without any of these symptoms preceding the others. Taken together, pain of any type seems to be much more frequent than NP in early nonprogressive MS. Moreover, the close relationship between pain, fatigue, and depression in MS should be considered for treatment decisions and future research on a possible common pathophysiology.Entities:
Mesh:
Year: 2020 PMID: 32197038 DOI: 10.1097/j.pain.0000000000001767
Source DB: PubMed Journal: Pain ISSN: 0304-3959 Impact factor: 6.961